Your browser doesn't support javascript.
loading
Loss of function mutations of BCOR in classical Hodgkin lymphoma.
Giefing, Maciej; Gearhart, Micah D; Schneider, Markus; Overbeck, Birte; Klapper, Wolfram; Hartmann, Sylvia; Ustaszewski, Adam; Weniger, Marc A; Wiehle, Laura; Hansmann, Martin-Leo; Melnick, Ari; Béguelin, Wendy; Sundström, Christer; Küppers, Ralf; Bardwell, Vivian J; Siebert, Reiner.
Afiliação
  • Giefing M; Institute of Human Genetics, Polish Academy of Sciences, Poznan, Poland.
  • Gearhart MD; Institute of Human Genetics, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein, Kiel, Germany.
  • Schneider M; Department of Genetics, Cell Biology and Development, Masonic Cancer Center and Developmental Biology Center, University of Minnesota, Minneapolis, USA.
  • Overbeck B; Institute of Cell Biology (Cancer Research), Medical Faculty, University of Duisburg-Essen, Essen, Germany, and Deutsches Konsortium für Translationale Krebsforschung (DKTK).
  • Klapper W; Department of Pediatric Hematology and Oncology, University Children's Hospital Essen, Essen, Germany.
  • Hartmann S; Institute of Human Genetics, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein, Kiel, Germany.
  • Ustaszewski A; Department of Pathology, Haematopathology Section and Lymph Node Registry, Christian-Albrechts University Kiel, Kiel, Germany.
  • Weniger MA; Reference and Consultant Center of Lymph Node and Lymphoma Pathology at Dr. Senckenberg Institute of Pathology, University of Frankfurt, Medical School, Frankfurt, Germany.
  • Wiehle L; Institute of Human Genetics, Polish Academy of Sciences, Poznan, Poland.
  • Hansmann ML; Institute of Cell Biology (Cancer Research), Medical Faculty, University of Duisburg-Essen, Essen, Germany, and Deutsches Konsortium für Translationale Krebsforschung (DKTK).
  • Melnick A; Institute of Human Genetics, University of Ulm and University of Ulm Medical Center, Ulm, Germany.
  • Béguelin W; Reference and Consultant Center of Lymph Node and Lymphoma Pathology at Dr. Senckenberg Institute of Pathology, University of Frankfurt, Medical School, Frankfurt, Germany.
  • Sundström C; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, New York, USA.
  • Küppers R; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, New York, USA.
  • Bardwell VJ; Department of Pathology, Uppsala University Hospital, Uppsala, Sweden.
  • Siebert R; Institute of Cell Biology (Cancer Research), Medical Faculty, University of Duisburg-Essen, Essen, Germany, and Deutsches Konsortium für Translationale Krebsforschung (DKTK).
Leuk Lymphoma ; 63(5): 1080-1090, 2022 05.
Article em En | MEDLINE | ID: mdl-34957890
ABSTRACT
BCOR is a component of a variant Polycomb repressive complex 1 (PRC1.1). PRC1 and PRC2 complexes together constitute a major gene regulatory system critical for appropriate cellular differentiation. The gene is upregulated in germinal center (GC) B cells and mutated in a number of hematologic malignancies. We report BCOR inactivating alterations in 4/7 classic Hodgkin lymphoma (cHL) cell lines, subclonal somatic mutations in Hodgkin and Reed-Sternberg (HRS) cells of 4/10 cHL cases, and deletions in HRS cells of 7/17 primary cHL cases. In mice, conditional loss of Bcor driven by AID-Cre in GC B cells resulted in gene expression changes of 46 genes (>2-fold) including upregulated Lef1 that encodes a transcription factor responsible for establishing T-cell identity and Il9r (interleukin-9 receptor), an important member of the cytokine network in cHL. Our findings suggest a role for BCOR loss in cHL pathogenesis and GC-B cell homeostasis.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Hodgkin Limite: Animals / Humans Idioma: En Revista: Leuk Lymphoma Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Polônia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Hodgkin Limite: Animals / Humans Idioma: En Revista: Leuk Lymphoma Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Polônia